NexGel, Inc Warrant

NEXGEL has created a spin-off company, NexGelRx, to focus exclusively on developing prescription drug delivery solutions using its proprietary hydrogel technology. NEXGEL will retain a 19.99% non-dilutive equity stake and receive a 5% perpetual global royalty.

NEXGEL reported stable Q3 2025 revenue of $2.9 million, improved gross profit margins, and narrowed adjusted EBITDA losses. The company signed new partnerships, launched product lines, and received non-dilutive financing from Stada, positioning for potential growth in Q4.

The article discusses several stocks to watch heading into Tuesday, including Helen of Troy, NEXGEL, SMART Global Holdings, DigitalOcean, and Kura Sushi USA. It provides details on the expected earnings and revenue for these companies.

NEXGEL, a manufacturer of hydrogel products, reported a 20% year-over-year increase in Q2 2024 revenue and projected significant revenue growth in the next two quarters. The company attributed the strong performance to new partnerships and robust demand for its Silly George brand.